Proctor and Gamble 2009 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2009 Proctor and Gamble annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 78

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78

40 The Procter & Gamble Company Management’s Discussion and Analysis
Net earnings declined 3% to $2.4billion in 2009 mainly due to lower
net sales. Net earnings margin was up 70 basis points due primarily
to lower SG&A as a percentage of net sales and higher current period
divestiture gains, partially offset by a lower gross margin. The decline
in gross margin was driven by higher commodity costs, which were
partially offset by price increases and manufacturing cost savings.
SG&A as a percentage of net sales was down behind reductions in
both marketing and overhead spending as a percentage of net sales.
Health Care net sales increased 9% in 2008 to $14.6billion behind
a 4% increase in unit volume. Foreign exchange had a positive 5%
impact on net sales and price increases added 1% to net sales.
Disproportionate growth in developing regions, which have selling
prices below the segment average, resulted in a negative 1% mix
impact. Feminine Care volume increased mid-single digits and organic
volume was up high single digits behind double-digit growth on
Naturella and high single-digit growth on Always, which more than
offset a low single-digit decline on Tampax. Our global feminine care
market share increased slightly in 2008. Oral Care volume was up mid-
single digits behind initiative-driven growth on Oral-B toothbrushes and
Crest. Volume in Pharmaceuticals and Personal Health was up low
single digits as the impact of adding the Swiss Precision Diagnostics
business was largely offset by lower shipments of Actonel, Prilosec
OTC and PuR. The PuR decline was from adjustments to a Whirlpool®
water filters licensing agreement. Prilosec OTC volume began to
decline in the third fiscal quarter of 2008 due to the loss of market-
place exclusivity and the entry of competing products into the market.
This is expected to continue and to have an adverse effect on the
results of the Health Care segment in future periods. Net earnings in
Health Care were up 12% in 2008 to $2.5billion due to higher net
sales and a 50-basis point improvement in net earnings margin. Net
earnings margin increased as reduced SG&A as a percentage of net
sales more than offset lower gross margin. Gross margin was down
due to higher commodity costs and a less profitable mix driven
primarily by disproportionate growth in developing regions and lower
shipments of Prilosec OTC, which more than offset the benefit of
increased volume scale leverage and manufacturing cost savings. SG&A
improved primarily behind lower overhead spending as a percentage
of net sales due to a focus on productivity improvement and Gillette
synergy benefits.
SNACKS AND PET CARE
($millions) 2009
Change vs.
Prior Year 2008
Change vs.
Prior Year
Volume n/a -6% n/a +3%
Net sales $3,114 -3% $3,204 +7%
Net earnings $234 -10% $261 +7%
Snacks and Pet Care net sales decreased 3% to $3.1billion in 2009
on a 6% decline in unit volume. Price increases to offset higher
commodity costs added 9% to net sales. Product mix reduced net
sales by 2% due to lower shipments of Eukanuba and premium snack
products, which have higher than segment average selling prices.
Unfavorable foreign exchange reduced net sales by 4%. Organic sales
increased 1%. Snacks volume decreased high single digits due to
lower merchandising support and trade inventory levels, a high base
period, which included the Rice Infusion, Extreme Flavors and Stix
product launches and market share declines following price increases.
Our global snacks market share declined about 1 point versus the prior
year. Volume in Pet Care declined mid-single digits mainly due to
declines in premium nutrition business following multiple price increases.
Net earnings in 2009 were down 10% to $234million on lower
net sales and a 60-basis point reduction in net earnings margin.
A reduction in gross margin and a higher effective tax rate each
reduced net earnings margin. These impacts were partially offset by
lower SG&A as a percentage of net sales. Gross margin declined due
to higher commodity costs, partially offset by higher selling prices
and manufacturing cost savings. SG&A as a percentage of net sales
declined due to reductions in both marketing and overhead spending.
Snacks and Pet Care net sales increased 7% to $3.2billion in 2008.
Net sales grew behind a 3% volume increase, a positive 1% price
impact resulting from price increases in Pet Care and a 4% favorable
foreign exchange impact. Product mix had a negative 1% impact on
net sales from an increase in Snacks volume, which has lower selling
prices than the segment average. Snacks volume was up high single
digits behind the launch of Rice Infusion in Western Europe and Extreme
Flavors and Pringles Stix in North America. In Pet Care, volume was
down low single digits due to negative impacts from the voluntary
wet pet food recall in the U.S. in March 2007 that contributed to
approximately a 1% decline in our U.S. market share. Net earnings in
Snacks and Pet Care were up 7% to $261million in 2008 due to sales
growth. Operating margin was consistent with the prior year as lower
gross margin was offset by improved SG&A as a percentage of net
sales. Gross margin was down as higher commodity costs across the
segment more than offset price increases, base period pet food
recall impacts and manufacturing cost savings. SG&A decreased as a
percentage of net sales due to reductions in both overhead and
marketing spending as a percentage of net sales.
Household Care
FABRIC CARE AND HOME CARE
($millions) 2009
Change vs.
Prior Year 2008
Change vs.
Prior Year
Volume n/a -3% n/a +6%
Net sales $23,186 -2% $23,714 +11%
Net earnings $3,032 -11% $3,411 +9%
Fabric Care and Home Care net sales were down 2% in 2009 to
$23.2billion on a 3% decline in unit volume. Price increases, taken
primarily to offset higher commodity costs, added 6% to net sales,
while unfavorable foreign exchange reduced net sales by 5%.
Organic sales increased 3%. Fabric Care, Home Care and Batteries
unit volume were each down in both developed and developing
regions. Volume in Fabric Care declined low single digits due to trade
inventory reductions and net market share declines following price
increases. Lower shipments of premium-priced Tide and Ariel were
only partially offset by growth of Gain and Downy. Global value share
of the fabric care market was down less than half a point behind